|
Sudarshan Pharma Industries Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
577.58 Cr.
|
P/BV
|
4.13
|
Book Value (Rs.)
|
5.82
|
|
52 Week High/Low (Rs.)
|
39/19
|
FV/ML
|
1/4000
|
P/E(X)
|
36.20
|
|
Bookclosure
|
23/11/2024
|
EPS (Rs.)
|
0.66
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 505.05 | 463.54 | 461.33 | 357.09 | 193.35 |
| Total Operating Revenues | 505.05 | 463.54 | 461.33 | 357.09 | 193.35 |
| | | | | | |
| Other Income | 2.52 | 2.61 | 1.12 | 0.46 | 0.38 |
| Total Revenue | 507.57 | 466.15 | 462.45 | 357.56 | 193.73 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 8.93 | 6.31 | 0.32 | 360.81 | 185.88 |
| Purchase Of Stock-In Trade | 485.18 | 424.04 | 457.25 | 0.00 | 0.00 |
| Operating And Direct Expenses | 10.32 | 8.79 | 8.13 | 0.00 | 0.00 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -54.35 | -7.87 | -26.62 | -22.91 | -6.59 |
| Employee Benefit Expenses | 4.89 | 3.64 | 2.98 | 2.43 | 1.62 |
| Finance Costs | 15.77 | 8.94 | 5.40 | 3.38 | 3.23 |
| Depreciation And Amortisation Expenses | 2.22 | 1.24 | 0.91 | 0.87 | 0.74 |
| Other Expenses | 10.16 | 5.82 | 4.59 | 5.79 | 5.27 |
| Total Expenses | 483.12 | 450.92 | 452.95 | 350.37 | 190.15 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 24.45 | 15.23 | 9.50 | 7.19 | 3.57 |
| | | | | | |
| Exceptional Items | -2.82 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 21.63 | 15.23 | 9.50 | 7.19 | 3.57 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 5.49 | 3.98 | 2.42 | 1.88 | 0.85 |
| Deferred Tax | 0.27 | -0.16 | 0.04 | 0.00 | 0.06 |
| Tax For Earlier Years | -0.08 | -0.05 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses | 5.68 | 3.77 | 2.46 | 1.89 | 0.90 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 15.95 | 11.46 | 7.04 | 5.30 | 2.67 |
| | | | | | |
| Profit/Loss From Continuing Operations | 15.95 | 11.46 | 7.04 | 5.30 | 2.67 |
| | | | | | |
| Profit/Loss For The Period | 15.95 | 11.46 | 7.04 | 5.30 | 2.67 |
| Consolidated Profit/Loss After MI And Associates | 15.96 | 11.46 | 7.04 | 5.30 | 2.67 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 0.66 | 4.76 | 5.48 | 5.52 | 2.80 |
| Diluted EPS (Rs.) | 0.66 | 4.76 | 5.48 | 5.52 | 2.80 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.72 | 0.00 | 0.00 | 0.00 |
